Literature DB >> 16154714

The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence.

Anna Williamson1, Shane Darke, Joanne Ross, Maree Teesson.   

Abstract

AIMS: To determine the effects of cocaine use across the study period on outcomes of treatment for heroin dependence 12 months post-treatment entry.
DESIGN: Longitudinal cohort (12 months). Interviews were conducted at baseline, 3 and 12 months.
SETTING: Sydney, Australia. PARTICIPANTS: Four hundred ninety-five heroin users recruited for the Australian Treatment Outcome Study and re-interviewed at 12-month follow-up.
FINDINGS: Cocaine was widely used among treatment entrants in NSW, with almost all having a lifetime history of cocaine use and almost half having used in the month preceding baseline. While there was an overall decline in cocaine use across the study period, individual use patterns varied widely. Approximately half of the cohort did not report cocaine use at any data point, with the remainder reporting having used at one (29%), two (12%), or at all three (5%) points. Cocaine use across the study period was an independent predictor of most major treatment outcomes, with more cocaine use points predicting poorer outcome. Persistent cocaine use predicted a higher prevalence of homelessness, heroin use, daily injecting, needle sharing and injection-related health problems at 12 months as well as more extensive recent polydrug use.
CONCLUSIONS: Cocaine use was common among individuals seeking treatment for primary heroin dependence in NSW. Any cocaine use over the study period was associated with poorer outcomes in virtually all areas. Persistent cocaine use over the study period, however, appeared particularly detrimental. Cocaine use among clients should evidently be a cause for concern amongst treatment providers and may warrant being specifically targeted during treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16154714     DOI: 10.1016/j.drugalcdep.2005.08.010

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  34 in total

1.  Self-administration of cocaine and remifentanil by monkeys: choice between single drugs and mixtures.

Authors:  Kevin B Freeman; William L Woolverton
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

2.  Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response.

Authors:  Sarah W Yip; Elise E DeVito; Hedy Kober; Patrick D Worhunsky; Kathleen M Carroll; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2016-07-16       Impact factor: 4.492

3.  Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.

Authors:  David R Maguire; Charles P France
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

4.  Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.

Authors:  M Eugenia Socías; Evan Wood; Will Small; Huiru Dong; Jean Shoveller; Thomas Kerr; Julio Montaner; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2016-09-20       Impact factor: 4.492

5.  Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients.

Authors:  Danielle Barry; Brendan Sullivan; Nancy M Petry
Journal:  Psychol Addict Behav       Date:  2009-03

6.  Meta-analysis of depression and substance use and impairment among cocaine users.

Authors:  Kenneth R Conner; Martin Pinquart; Amanda P Holbrook
Journal:  Drug Alcohol Depend       Date:  2008-06-27       Impact factor: 4.492

7.  Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.

Authors:  Yih-Ing Hser; Elizabeth Evans; David Huang; Robert Weiss; Andrew Saxon; Kathleen M Carroll; George Woody; David Liu; Paul Wakim; Abigail G Matthews; Mary Hatch-Maillette; Eve Jelstrom; Katharina Wiest; Paul McLaughlin; Walter Ling
Journal:  Addiction       Date:  2016-01-13       Impact factor: 6.526

8.  Using enhanced and integrated services to improve response to standard methadone treatment: changing the clinical infrastructure of treatment networks.

Authors:  Karin Neufeld; Michael Kidorf; Van King; Ken Stoller; Michael Clark; Jessica Peirce; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2009-08-29

9.  The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance.

Authors:  Brent A Moore; Tera Fazzino; Declan T Barry; David A Fiellin; Christopher J Cutter; Richard S Schottenfeld; Samuel A Ball
Journal:  J Subst Abuse Treat       Date:  2013-01-30

10.  Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders.

Authors:  Danielle Barry; Jeremiah Weinstock; Nancy M Petry
Journal:  Drug Alcohol Depend       Date:  2008-08-06       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.